Spruce Biosciences, Inc. operates as a biotechnology company. The Company offers endocrinology and orphan drug development to meet the unmet need of patients suffering from endocrine disorders. Spruce Biosciences serves patients in the United States.

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Current Report (Form 8-K | Period ending 2024-08-12)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Spruce Biosciences (SPRB US)

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Current Report (Form 8-K | Period ending 2024-08-12)

Current Report (Form 8-K | Period ending 2024-06-13)

Current Report (Form 8-K | Period ending 2024-06-02)

Current Report (Form 8-K | Period ending 2024-05-22)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)